Development of the first way to make large amounts of promising anti-cancer substance
By American Chemical Society Wednesday, March 6, 2013
Scientists are reporting development of the first practical way to make large amounts of a promising new anti-cancer substance that kills cancer cells differently than existing medicines. Their article on synthesis of the substance, and tests demonstrating its effectiveness in the laboratory, appears in ACS’ Journal of Medicinal Chemistry.
The nose that can smell cancer goes commercialBy Guest Column Wednesday, February 20, 2013
An Israeli invention that can detect lung cancer from exhaled breath will be commercialized in a joint venture between the Technion-Israel Institute of Technology and Alpha Szenszor, a Boston-based manufacturer of carbon nanotube sensing equipment.
Development of the first way to make large amounts of promising anti-cancer substanceBy American Chemical Society Wednesday, January 16, 2013
Scientists are reporting development of the first practical way to make large amounts of a promising new anti-cancer substance that kills cancer cells differently than existing medicines. Their article on synthesis of the substance, and tests demonstrating its effectiveness in the laboratory, appears in ACS’ Journal of Medicinal Chemistry.
The Mortality Rate is Staggering for Lung CancerBy Dr. Gifford Jones Sunday, August 19, 2012
My patients always give me the wrong answer when I ask them, “What cancer kills women more than any other malignancy?” Most say, “Breast cancer”. But lung cancer kills more women than breast and colon/rectal cancer combined. But there’s hope for both sexes.
Chemotherapy can backfire and boost cancer growth: studyBy News on the Net Monday, August 6, 2012
Exciting New Cancer Treatment Receives Approval For Human Clinical Trials
By News on the Net Saturday, June 9, 2012
Boynton Beach, FL, - Chances are, you know someone who has been diagnosed with cancer. One out of every three women will contract the disease in their lifetime; for men the odds are even greater. Now, an exciting new protocol has received approval from the FDA and WIRB (Western Institutional Review Board) to conduct a Phase I/II clinical trial on humans for treatment of solid tumor (metastic) cancers using a treatment designed to “supercharge the patient’s immune system and “zap” the cancer cells, destroying them.”
Nanomedicines promise fewer side effects in treating cancerBy American Chemical Society Wednesday, June 6, 2012
Chemical & Engineering News
A new generation of cancer treatments based on nanotechnology is making its way out of the laboratory and into the clinic with the promise of targeting cancer cells while steering clear of healthy tissue, according to the current edition of Chemical & Engineering News (C&EN). C&EN is the weekly newsmagazine of the American Chemical Society (ACS), the world’s largest scientific society.
Ten Ways to Reduce the Risk of CancerBy Dr. Gifford Jones Sunday, May 20, 2012
Here’s the bad news! Nearly half of today’s North American men and one-third of women will develop cancer, making it the second leading cause of death after heart disease. To some people, fate deals a bad hand when they inherit genes that increase the risk of cancer. But here’s the good news. Drs. John Swartzberg and Jeffery Wolf at the University of California say that lifestyle changes can help people reduce the risk of at least 65 percent of cancers.
The Hazards Of The Closed CarBy Dr. Gifford Jones Monday, January 2, 2012
What’s the best way this holiday season to expose your child to nicotine and the cancer-causing compounds in tobacco smoke? A report in the British Medical Association Journal says it’s very easy. Take your children for a car ride, keep the windows closed and smoke cigarettes.
“Gifford-Jones, They Don’t Want To Hear That!”By Dr. Gifford Jones Sunday, December 11, 2011
Several years ago a friend asked if I’d talk to a women’s organization about breast cancer, how mammography could detect malignancy in its early stages. But when I gave her a short version of what I intended to say, she remarked, “But they would not like to hear that!” End of the talk. So what do women not want to hear?
Armenian Study: Induced Abortion Nearly Triples Breast Cancer Risk
By Christian Newswire Monday, November 28, 2011
HOFFMAN ESTATES, Ill., The Coalition on Abortion/Breast Cancer notes that an Armenian study-whose authors examined diabetes mellitus type 2, reproductive factors, and breast cancer-found a statistically significant association showing a 2.86-fold increased breast cancer risk from one induced abortion. [1] The study, led by Lilit Khachatryan, included researchers from Johns Hopkins School of Public Health and the University of Pennsylvania.
Who Says That Heroin is an Illegal Painkiller?By Dr. Gifford Jones Monday, November 7, 2011
The Globe and Mail was wrong in a recent column about the in-site heroin clinic in Vancouver, when it stated that heroin was an illegal drug. Its editors have forgotten that when I wrote for the G and M I spent thousands of dollars placing ads in the newspaper during a campaign to legalize heroin. And that Jake Epp, The Minister of Health, announced on Dec 4, 1984, that heroin would be legalized to treat terminal cancer pain.
By Guest Column Wednesday, October 19, 2011
The “Lance Armstrong effect” could become a powerful new weapon to fight cancer cells that develop resistance to chemotherapy, radiation and other treatments, scientists say in a report in the ACS journal Molecular Pharmaceutics.
Robert Getzenberg and Donald Coffey explain that many advances have occurred in the 40 years since President Nixon declared a “War on Cancer” on December 23, 1971. However, cancer remains a leading cause of death worldwide, claiming almost 8 million lives annually. Patients with some forms of cancer respond well to treatment, while others have disease that becomes resistant to every known treatment. Patients with testicular cancer have a high survival rate — more than 70 percent — even if the cancer metastasizes, or spreads. For example, Lance Armstrong, the famous cyclist, beat metastatic testicular cancer that spread to his lungs and brain, and then went on to win the Tour de France a record seven consecutive times. But patients with pancreatic cancer have only a 25 percent survival rate in the first year and a 6 percent survival rate by the fifth year after diagnosis. Why is this?
The 2011 Terry Fox RunBy Guest Column Wednesday, September 14, 2011
Greetings:
The Terry Fox Run is this Sunday, September 18th at more than 230 cities, towns and communities across Ontario. It also takes place in more than 30 countries around the world.
When In Doubt, Cut it OutBy Dr. Gifford Jones Sunday, August 7, 2011
“Is it a benign mole or a malignant melanoma?” you wonder. This is an important question as the number of cases of melanoma continues to increase. It’s shocking that the incidence of new cases is now greater than the combined number of breast, lung, prostate and large bowel cancers. So how can you prevent dying from this disease?
Rudyard Kipling, the English novelist, gave some sound advice when he wrote, “Only mad dogs and Englishmen go out in the noonday sun”. Too much sun exposure is the cause of many melanomas. Remember that if your shadow is shorter than you, it’s time to get out of the sun.
Next 15 Columns
